Physician

Andrew Neuschatz, M.D.

According to 2025 Medicare claims, Andrew Neuschatz, M.D. (NPI: 1124077185) practices radiation oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is ARIZONA ONCOLOGY ASSOCIATES PC (NPI: 1578587671; TIN: 860938204) and primary practice location at 85704-7891.

Neuschatz's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 321 traditional Medicare patients, billed 11,432 HCPCS/CPT codes, and received $1,288,936 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 118 prescription claims across 66 beneficiaries totaling $2,238 in drug costs, led by Mometasone Furoate (Mometasone Furoate). Open Payments data shows 32 records totaling $758. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $757,887 to $1,288,936. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,646 and ending at $2,238. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	238	4,589	$757,887
2016	232	4,847	$758,250
2017	199	4,077	$619,354
2018	202	4,811	$765,325
2019	213	5,191	$621,001
2020	374	4,819	$641,937
2021	254	4,158	$716,045
2022	317	5,733	$1,039,135
2023	374	9,435	$1,644,371
2024	321	11,432	$1,288,936

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	40	77	$1,646
2016	38	101	$2,228
2017	45	85	$2,756
2018	41	86	$1,285
2019	32	60	$1,310
2020	27	51	$778
2021	36	65	$3,243
2022	59	106	$2,224
2023	66	104	$1,836
2024	66	118	$2,238

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G6015	Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session	85	395	$270
G6012	Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev	94	334	$174
77427	Radiation treatment management, 5 treatment sessions	115	192	$146
77014	Ct guidance for insertion of radiation therapy fields	82	373	$91
77336	Continuing radiation therapy consultation per week	98	172	$67

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mometasone Furoate	Mometasone Furoate	15	380	$373
Ssd	Silver Sulfadiazine	14	385	$182

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$758	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Neuschatz, M.D.?

Tedicare shows public-source Medicare data for Andrew Neuschatz, M.D. (NPI 1124077185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Neuschatz, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Neuschatz, M.D.?

Andrew Neuschatz, M.D. is linked to ARIZONA ONCOLOGY ASSOCIATES PC (billing NPI 1578587671) in the available physician profile data.

Does Andrew Neuschatz, M.D. have Open Payments data?

Andrew Neuschatz, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.